What is the risk of placenta accreta during future pregnancies after a myomectomy where the endometrial cavity was entered?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

A. Increase - The risk of placenta accreta is increased when the endometrial cavity is entered during myomectomy, as this creates a full-thickness uterine defect that disrupts the endometrial-myometrial interface, establishing the pathophysiologic foundation for abnormal placental invasion in future pregnancies.

Mechanism of Increased Risk

The American College of Obstetricians and Gynecologists explains that placenta accreta spectrum develops when defects in the endometrial-myometrial interface lead to failure of normal decidualization in areas of uterine scarring, allowing abnormally deep placental anchoring and trophoblast infiltration 1.

Entry into the endometrial cavity during myomectomy is particularly significant because:

  • It creates a full-thickness defect similar to cesarean delivery, rather than a subserosal defect that would not involve the decidual layer 1
  • This disruption within the uterine cavity damages the endometrial-myometrial interface, affecting scar tissue development and increasing the likelihood of placenta accreta 1
  • The defect allows abnormal trophoblast invasion through defective decidua directly into the myometrium 2

Evidence Supporting Increased Risk

Prior uterine surgeries are explicitly listed as established risk factors for placenta accreta spectrum by the American College of Obstetricians and Gynecologists, alongside cesarean delivery, curettage, and Asherman syndrome 1. Multiple case reports and series confirm placenta accreta occurring at myomectomy sites 3, 4.

Previous myomectomy is recognized as a risk factor for abnormal placentation in the literature 5, and patients with a history of hysteroscopic myomectomy or other uterine leiomyoma treatment are at increased risk for abnormal placentation 4.

Critical Caveat: The Placenta Previa Factor

If placenta previa develops overlying the myomectomy scar, the risk escalates dramatically:

  • Similar to the well-established cesarean scar-previa combination that creates 11-67% accreta risk depending on the number of prior surgeries 1
  • When the placenta overlies any uterine abnormality, a careful search for invasive placentation is warranted 3
  • The combination of placenta previa and prior cesarean deliveries creates risk increasing from 11% with one cesarean to 67% with five or more 6

Quantifying the Absolute Risk

An important nuance: While one study found 0% placenta accreta in women with prior myomectomy (95% CI 0-1.98%) 7, this study likely included predominantly subserosal myomectomies where the endometrial cavity was NOT entered. The absolute magnitude of increased risk after myomectomy with endometrial cavity entry is not as precisely quantified as it is for cesarean delivery 1.

Recent evidence demonstrates that endometrial defects detected after uterine surgery are associated with 100% incidence of PAS when pregnancy occurs before endometrial restoration, compared to 20% when endometrial restoration occurs 8.

Clinical Implications for Future Pregnancies

Imaging surveillance is essential:

  • Gray-scale ultrasound should be the first-line imaging modality, looking for loss of the normal hypoechoic retroplacental zone, placental lacunae, thinning of the uterine serosa-bladder interface, and abnormal placental vascularity 1, 6
  • Imaging studies are suggested in patients with history of myomectomy to coordinate multidisciplinary care 4

If placenta accreta spectrum is diagnosed:

  • Delivery must occur at a level III or IV maternal care facility with a multidisciplinary team 2, 6
  • Planned delivery should occur at 34 0/7 to 35 6/7 weeks gestation 2, 6
  • The standard approach is cesarean hysterectomy with the placenta left in situ 2, 6

References

Guideline

Risk of Placenta Accreta After Myomectomy with Endometrial Cavity Entry

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Placenta Accreta Spectrum Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Placenta accreta: an association with fibroids and Asherman syndrome.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2008

Research

Placenta increta after hysteroscopic myomectomy.

Obstetrics and gynecology, 2013

Research

[Placenta accreta: screening, management and complications].

Gynecologie, obstetrique & fertilite, 2013

Guideline

Diagnosing and Managing Placenta Accreta Spectrum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.